Why the study?
Statins during radiation therapy associate with reduced long-term cardiovascular risk, but the mechanisms protecting the vasculature from irradiation injury remain poorly understood.
Does pretreatment with pravastatin or atorvastatin prevent radiation-induced injury in cultured human endothelial cells and mice?
Population
Cultured human coronary and umbilical vein endothelial cells and mice subjected to head-and-neck irradiation
Comparison
Pravastatin vs atorvastatin pretreatment
Design
Preclinical in vitro and in vivo mechanistic study
Follow-up
24 and 240 h after irradiation
Authors
Loading...
Hypothesis-generating for endothelial protection; leaves open clinical translation to reduced ASCVD after radiation.
Does pretreatment with pravastatin or atorvastatin prevent radiation-induced injury in cultured human endothelial cells and mice?
Pravastatin, a hydrophilic statin, may offer superior protection against radiation-induced mitochondrial injury and inflammation in endothelial cells compared to lipophilic atorvastatin.
Ait‐Aissa et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: